Engineered extracellular matrices facilitate brain organoids from human pluripotent stem cells

Ann Clin Transl Neurol. 2023 Jul;10(7):1239-1253. doi: 10.1002/acn3.51820. Epub 2023 Jun 7.

Abstract

Objective: Brain organoids are miniaturized in vitro brain models generated from pluripotent stem cells, which resemble full-sized brain more closely than conventional two-dimensional cell cultures. Although brain organoids mimic the human brain's cell-to-cell network interactions, they generally fail to faithfully recapitulate cell-to-matrix interactions. Here, an engineered framework, called an engineered extracellular matrix (EECM), was developed to provide support and cell-to-matrix interactions to developing brain organoids.

Methods: We generated brain organoids using EECMs comprised of human fibrillar fibronectin supported by a highly porous polymer scaffold. The resultant brain organoids were characterized by immunofluorescence microscopy, transcriptomics, and proteomics of the cerebrospinal fluid (CSF) compartment.

Results: The interstitial matrix-mimicking EECM enhanced neurogenesis, glial maturation, and neuronal diversity from human embryonic stem cells versus conventional protein matrix (Matrigel). Additionally, EECMs supported long-term culture, which promoted large-volume organoids containing over 250 μL of CSF. Proteomics analysis of the CSF found it superseded previous brain organoids in protein diversity, as indicated by 280 proteins spanning 500 gene ontology pathways shared with adult CSF.

Interpretation: Engineered EECM matrices represent a major advancement in neural engineering as they have the potential to significantly enhance the structural, cellular, and functional diversity that can be achieved in advanced brain models.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain
  • Extracellular Matrix
  • Humans
  • Neurogenesis
  • Organoids* / metabolism
  • Pluripotent Stem Cells*

Grants and funding

This work was funded by Robert and Katherine Jacobs Health Environmental Initiative Fund; Andrea and Lawrence A. Wolfe Brain Health Initiative Fund; National Science Foundation grant DGE 1256260; NeuroNetwork for Emerging Therapies; Robert E. Nederlander Sr. Program for Alzheimer's Research; University of Michigan Biointerfaces Institute.